Quick Answer
JUPITER NEUROSCIENCES, INC. reported Diluted EPS of $0.08 per share (loss) for fiscal year 2024.
JUPITER NEUROSCIENCES, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$0.08 | +55.6% |
| 2023 | -$0.18 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.07 | -250.0% | +0.0% |
| June 30, 2025 | -$0.07 | -800.0% | -40.0% |
| March 31, 2025 | -$0.05 | -150.0% | -150.0% |
| September 30, 2024 | -$0.02 | +71.4% | -300.0% |
| June 30, 2024 | $0.01 | — | +150.0% |
| March 31, 2024 | -$0.02 | — | +71.4% |
| September 30, 2023 | -$0.07 | — | — |
- JUPITER NEUROSCIENCES, INC. showed an increase of +55.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2024 period, JUPITER NEUROSCIENCES, INC.’s diluted eps has grown by 55.6% (from $0.18 per share (loss) to $0.08 per share (loss)).
- The most recent figure is from JUPITER NEUROSCIENCES, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: